Alphamab

Developer of antibody and protein-based biopharmaceuticals

placeSuzhou, Jiangsu, China calendar_todayFounded 2009 groups437 employees language alphamab.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 6 times.

YearFilings
20121
20151

Investor mix

5 investors on record; lead investors include Hudson Bay Capital.

Investor typeCountShare
Venture capital120%
Private equity120%
Other / undisclosed360%
Coming soon